Home › Diffuse Large B-Cell Lymphoma › Oklahoma
Diffuse Large B-Cell Lymphoma clinical trials in Oklahoma
5 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in Oklahoma.
Cities in Oklahoma
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- University of Oklahoma Health Sciences Center, Oklahoma City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT06015880Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
- University of Oklahoma, Oklahoma City
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Mar 10, 2026 · NCT05256641Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- University of Oklahoma Health Sciences Center, Oklahoma City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 2, 2026 · NCT05633615Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
- University of Oklahoma Health Sciences Center, Oklahoma City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 20, 2025 · NCT05890352A Study of NX-1607 in Adults With Advanced Malignancies
- University of Oklahoma, Oklahoma City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT05107674From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.